Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-06 Purchase | 2024-05-07 5:06 pm | Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks | 20,000 | $1.7312 | $34,624 | 173,130 (Direct) | View |
| 2024-05-06 Purchase | 2024-05-07 5:05 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO | 577,634 | $1.7312 | $1,000,000 | 2,626,826 (Indirect Direct) | View |
| 2023-05-15 Purchase | 2023-05-16 4:54 pm | Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director | 10,000 | $2.45 | $24,500 | 10,000 (Direct) | View |
| 2022-12-20 Purchase | 2022-12-20 6:22 pm | Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks | 20,000 | $0.79 | $15,800 | 133,773 (Direct) | View |
| 2022-12-13 Purchase | 2022-12-15 4:33 pm | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer | 34,000 | $0.75409 | $25,639 | 282,444 (Indirect) | View |
| 2022-12-13 Purchase | 2022-12-15 4:32 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO | 60,000 | $0.74712 | $44,827 | 1,490,119 (Indirect) | View |
| 2022-09-28 Purchase | 2022-09-28 5:45 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO | 25,000 | $0.7628 | $19,070 | 1,430,119 (Indirect Direct) | View |
| 2022-09-20 Purchase | 2022-09-20 6:58 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO | 20,000 | $0.81266 | $16,253 | 1,405,119 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-13 Option Award | 2024-06-17 6:46 pm | N/A 2034-06-13 | Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:48 pm | N/A 2034-06-13 | Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:44 pm | N/A 2034-06-13 | Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:43 pm | N/A 2034-06-13 | Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner | 15,000 | $0 | 3,290,616 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:41 pm | N/A 2034-06-13 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 6,958,654 (Direct) | View |
| 2024-05-10 Gift | 2024-05-14 5:02 pm | N/A N/A | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO | 302,016 | $0 | 1,765,737 (Indirect) | View |
| 2024-02-28 Option Award | 2024-03-01 5:57 pm | N/A 2034-02-28 | Corvus Pharmaceuticals Inc. | CRVS | Arcara Jeffrey Chief Business Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2023-12-06 Option Award | 2023-12-08 4:09 pm | N/A 2033-12-06 | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-12-06 Option Award | 2023-12-08 4:08 pm | N/A 2033-12-06 | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-12-06 Option Award | 2023-12-08 4:07 pm | N/A 2033-12-06 | Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-12-06 Option Award | 2023-12-08 4:06 pm | N/A 2033-12-06 | Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-12-06 Option Award | 2023-12-08 4:05 pm | N/A 2033-12-06 | Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-12-06 Option Award | 2023-12-08 4:04 pm | N/A 2033-12-06 | Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-12-06 Option Award | 2023-12-08 4:03 pm | N/A 2033-12-06 | Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-12-06 Option Award | 2023-12-08 4:03 pm | N/A 2033-12-06 | Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner | 15,000 | $0 | 3,290,616 (Direct) | View |
| 2023-12-06 Option Award | 2023-12-08 4:02 pm | N/A 2033-12-06 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 6,958,654 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:03 pm | N/A 2033-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 6,958,654 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:01 pm | N/A 2033-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner | 15,000 | $0 | 3,290,616 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:00 pm | N/A 2033-06-15 | Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:59 pm | N/A 2033-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:58 pm | N/A 2033-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:57 pm | N/A 2033-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-03 4:30 pm | N/A 2033-03-31 | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO | 800,000 | $0 | 800,000 (Direct) | View |
| 2022-08-11 Option Award | 2022-08-15 6:49 pm | N/A 2032-08-11 | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer | 160,000 | $0 | 160,000 (Direct) | View |
| 2022-08-11 Option Award | 2022-08-15 6:47 pm | N/A 2032-08-11 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 6,958,654 (Direct) | View |
| 2022-08-11 Option Award | 2022-08-15 6:44 pm | N/A 2032-08-11 | Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks | 160,000 | $0 | 160,000 (Direct) | View |
| 2022-08-11 Option Award | 2022-08-15 6:44 pm | N/A 2032-08-11 | Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-08-11 Option Award | 2022-08-15 6:40 pm | N/A 2032-08-11 | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO | 320,000 | $0 | 320,000 (Direct) | View |
| 2022-08-11 Option Award | 2022-08-15 6:39 pm | N/A 2032-08-11 | Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director | 15,000 | $0 | 15,000 (Direct) | View |